"Scopolamine Derivatives" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Analogs or derivatives of scopolamine.
| Descriptor ID |
D012602
|
| MeSH Number(s) |
D02.145.074.722.822 D03.132.889.601 D03.605.084.500.722.822 D03.605.869.822
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Scopolamine Derivatives".
Below are MeSH descriptors whose meaning is more specific than "Scopolamine Derivatives".
This graph shows the total number of publications written about "Scopolamine Derivatives" by people in this website by year, and whether "Scopolamine Derivatives" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 4 | 0 | 4 |
| 2011 | 3 | 0 | 3 |
| 2013 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Scopolamine Derivatives" by people in Profiles.
-
Long-acting bronchodilators in COPD: an evolving story. Lancet Respir Med. 2013 Sep; 1(7):499-501.
-
Indacaterol for chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One. 2013; 8(8):e70784.
-
Ten years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis. 2013; 8:117-25.
-
Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. Respir Med. 2012 Jan; 106(1):91-101.
-
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD. Eur Respir J. 2011 Oct; 38(4):797-803.
-
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6.
-
Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther. 2009 Nov; 26(11):1024-34.
-
Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2009 Dec; 22(6):587-92.
-
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet. 2009 Aug 29; 374(9691):695-703.
-
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Drugs. 2009 Jun 18; 69(9):1205-16.